Ignite Creation Date:
2024-07-17 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06484920
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-06-19
Brief Title:
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Sponsor:
Rita Assi
Organization:
Indiana University
Organization Data
Organization:
Indiana University
Class:
OTHER
Study ID:
CTO-IUSCCC-0866
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rita Assi
Lead Sponsor Class:
OTHER
Responsible Party:
Rita Assi
Responsible Party Title:
Assistant Professor of Medicine
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Indiana University
Old Name:
None
Old Organization:
None